Table 2.
Information about the studies that evaluated mHealth systems.
| Reference | Intervention name | Year | Country | Study design | Duration | Health condition | Participants | Intended secondary users | Others involved in the intervention | Medical device included (Y/N) | Other devices included |
| [50] | SUPPORT-HF Study | 2015 | UK | Cross-sectional study | 45 weeks | Heart failure | Patients (n=26) | Health care providers | Health care providers and informal care givers | Y | Blood pressure monitor, weight scales, and pulse oximeter |
| [51] | —a | 2015 | USA | Cross-sectional study | Single evaluation | Diabetes | Patients (n=87) and health care providers (n=5) | Health care providers | Health care providers | Y | Glucose meter |
| [52] | Multiple commercial technologies for activity tracking | 2015 | USA | Prospective study | 80-100 days (mean 12.5 weeks) | Serious mental health conditionb | Patients (n=10) | Health care providers and peers (optional) | N/Ac | N | Wearable activity monitoring devices |
| [53] | Diabetes Diary app | 2015 | Norway | Prospective study | 2 weeks | Type 1 diabetes | Patients (n=6) | N/A | N/A | Y | Smart-watch app and glucose meter |
| [54] | Diabetes Diary app | 2015 | Norway | RCTd | 23 weeks | Type 1 diabetes | Patients (n=30) | N/A | N/A | Y | Glucose meter |
| [55] | Diabetes Diary app | 2016 | Norway | RCT |
48 weeks | Type 2 diabetes | Patients (n=151) | Health care providers | N/A | Y | Glucose meter |
| [56] | SnuCare | 2016 | Korea | Prospective study | 8 weeks | Asthma | Patients (n=44) | N/A | Research team | Y | Peak flow meter |
| [57] | HealthyCircles Platform | 2016 | USA | RCT | 24 weeks | Hypertension | Patients (n=52) | Health care providers | Health care providers | Y | Withings blood pressure monitor |
| [58] | Multiple commercial technologies for activity tracking | 2016 | USA | Prospective study | 24 weeks | Serious mental health conditionb | Patients (n=11) | N/A | N/A | N | Fitbit Zip |
| [35]e | Multiple commercial apps for heart failure | 2016 | USA | Cross-sectional study | Single evaluation | Stroke | Apps (n=34) | Family, friends, and health care providers (not all apps) | N/A | N | Y |
| [59] | Electronic Patient Reported Outcome tool (ePRO) | 2016 | Canada | Prospective study | 4 weeks | Multiple | Patients (n=8) and health care providers (n=6) | Health care providers | Health care providers | N | N |
| [60] | STARFISH | 2016 | UK | Prospective study | 6 weeks | Stroke | Patients (n=23) | Peers (automatic) | N/A | N | ActivPAL™ activity monitor |
| [61] | HeartMapp | 2016 | USA | Cross-sectional study | Single evaluation | Heart failure | Patients (n=25) and health care providers (n=12) | Health care providers | Health care providers | Y | Zephyr Bioharness or Biopatch |
| [62] | EDGE digital health system | 2017 | UK | RCT | 48 weeks | Chronic obstructive pulmonary disease | Patients (n=110) and research nurses (n=2) | Health care providers (automatic) | Informal care givers | N | N |
| [63] | IBGStar Diabetes Manager Application | 2017 | Germany | Prospective study | 12 weeks | Diabetes | Patients (n=51) | N/A | N/A | Y | iBGStar blood glucose meter |
| [64] | MyHeart | 2017 | USA | Prospective study | 24 weeks | Heart failure | Patients (n=8) and nurses | Nurses (automatic) | Nurses | Y | Weight scale, blood pressure monitor, and glucose meter |
| [65] | — | 2018 | UK | Cross-sectional study | 4 weeks | Cancer | Patients (n=23) | Peers and health care providers | N/A | N | N |